Construction of a 56,000 sq ft UK life science facility has been completed, Aviva Investors has announced. 

Chesterford Research Park, owned by Aviva Investors, now includes ten fully-fitted research and development suites spread over three floors, bringing capacity to approximately 385,000 sq ft of net internal space to UK life science enterprises. 

The company says the Sidney Sussex building has been designed specifically to support life science companies through their growth journey from startup to scale-up. Designed to be flexible and scalable, with the ability to combine suites for larger requirements, the space includes modern laboratory facilities alongside dedicated, open-plan, office areas.  

“We are very proud to offer a significant increase in capacity at Chesterford Research Park, and to unveil these exceptional facilities in the new Sidney Sussex building,” said Julian Cobourne, Head of Regional Investment Management at Aviva Investors. 

“Cambridge is an exciting and dynamic city and remains an important investment location. With a high concentration of life science companies in the region, from university spinouts through to globally leading brands, this is a great example of how we are continuing to enhance our real estate portfolio and helping the UK get ready for the future by providing high-growth sectors with environments to thrive in whilst also supporting long-term investment outcomes.”